[Serous fluid cytopathology : International system: Ancillary studies for serous fluids and special considerations for peritoneal washings].

Cytopathologie des séreuses : la classification internationale : À propos des techniques ancillaires prédictives et du cas particulier des lavages péritonéaux.
Ancillary predictive tests Classification internationale Cytopathologie Cytopathology International system Lavage péritonéal Peritoneal washing Serous fluid Séreuses Techniques ancillaires prédictives

Journal

Annales de pathologie
ISSN: 0242-6498
Titre abrégé: Ann Pathol
Pays: France
ID NLM: 8106337

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 13 12 2022
accepted: 15 03 2023
medline: 13 11 2023
pubmed: 29 8 2023
entrez: 28 8 2023
Statut: ppublish

Résumé

The International System for serous fluids cytopathology is a cytologic classification which purpose is to establish a consensus on diagnostic terminology. The exponential discovery of prognostic and theranostic molecular alterations in many cancers, particularly in advanced stages, led the authors to describe the indications and the feasibility of these new markers on cytological samples from serous effusions. The various immunocytochemistry techniques, FISH and those testing DNA and RNA are reported in regard to their ability to identify the main targets currently explored in routine practice. The vast majority of these crucial markers can be reliably tested on effusion fluids. The International System for serous effusion fluids also includes a chapter dedicated to peritoneal washings and the application of the classification to this particular type of sample. The objective is to "wash" the peritoneal cavity with a saline solution to unfix cells from the cavity's wall and collect those that have previously naturally detached. This procedure, performed before surgery of tumors and before any manipulation, allows a cytological analysis that specifies the staging of gynecological and non-gynecological tumors and excludes occult malignant cells in the presence of tumors appearing benign.

Identifiants

pubmed: 37640575
pii: S0242-6498(23)00081-0
doi: 10.1016/j.annpat.2023.03.005
pii:
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

452-461

Informations de copyright

Copyright © 2023. Published by Elsevier Masson SAS.

Auteurs

Céline Basset (C)

Département d'anatomie et de cytologie pathologiques, institut universitaire du cancer Toulouse oncopôle, 1, avenue Irène Joliot Curie, 31059 Toulouse cedex, France. Electronic address: basset-leobon.c@chu-toulouse.fr.

Laetitia Collin (L)

Medipath Feuillants, 116, route d'Espagne, Hélios 3, 31100 Toulouse, France.

Philippe Vielh (P)

Medipath et hôpital Américain de Paris, 17, rue Gazan, 75014 Paris, France.

Monique Courtade-Saïdi (M)

Département d'anatomie et de cytologie pathologiques, institut universitaire du cancer Toulouse oncopôle, 1, avenue Irène Joliot Curie, 31059 Toulouse cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH